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Abstract
Von-Hippel-Lindau (VHL) syndrome is characterized by focal vasoproliferative tumors of retinal capillaries called retinal capillary hemangio-
blastomas (RCH). These tumors are initially small and can be easily missed if  not looked for carefully. As they grow, these tumors are more 
demanding to treat and hence the importance of detecting them early and treating them. Herein, we describe and review the optical coherence 
tomography angiography (OCTA) of the early- stage lesion, which suggested the involvement of superficial and a deeper retinal capillary plexus. 
In addition, to helping us detect these lesions earlier, OCTA may also help to understand the in vivo changes occurring at an earlier phase.
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Von-Hippel-Lindau (VHL) syndrome is an exceedingly rare, 
multi-organ disease with a prevalence of one in 230,000, 
characterized by the development of focal benign or malig-
nant vasoproliferative tumors (hemangioblastoma). The 
syndrome occurs because of the mutation in the VHL gene 
(chromosome 3) and consequent increased expression of 
vascular endothelial growth factor (VEGF), platelet-derived 
growth factor (PDGF), erythropoietin (EPO), and  trans-
forming growth factor (TGF). Systemic manifestations of 
VHL include hemangioblastomas in the brain and spinal 
cord, renal and pancreatic cysts, pheochromocytoma, islet 
cell tumors, epididymal cystadenomas, endolymphatic sac 
tumor of the inner ear, and adnexal papillary cystadenoma 
of probable mesonephric origin (AMPO) of the broad lig-
ament. All the systemic features are manifested in only a 
few cases with VHL, whereas only 50% of patients display 
only one systemic feature. Many of these manifestations may 
occur years after the initial presentation and evolves over a 
long period (complete penetrance of VHL is seen by 65 years 
of age) (1).
Retinal capillary hemangioblastoma (RCH) is a clinically 
visible pathology that develops in 44%–66% of patients, 
usually in the third decade. These tumors develop denovo 
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from the retinal vascular plexus and progress from an occult 
angioma to huge angiomas with subsequent complex ret-
inal detachments (2). New lesions develop over a variable 
time frame and are also detected in the fifth decade of life. 
In the early stages, the lesions develop away from the fovea, 
without any visual disturbances. Hence the chances of them 
getting undetected is high. The various treatment modalities 
for retinal angioma are laser photocoagulation, cryotherapy, 
plaque radiotherapy, external beam radiation, proton beam 
radiation, photodynamic therapy (PDT), trans-pupillary 
thermotherapy, intraocular injection of anti-VEGF drugs or 
triamcinolone acetonide (TA), and vitreoretinal surgery (if  
associated with retinal detachment). 
Laser photocoagulation is the most common modality 
used because of its ease of use, fewer side effects, and results. 
The different photocoagulation techniques are direct pho-
tocoagulation of angioma, treatment of the feeder’s vessel, 
or a combination of both. Smaller lesions are more amena-
ble to regress with treatment, whereas larger lesions require 
numerous treatment sessions. However, it is effective in 
lesions up to 4.5 mm size only and is used for peripheral and 
juxtapapillary lesions. Apart from laser therapy, trans-scleral 
cryotherapy is effective for the destruction of these lesions, 
even in the presence of simultaneous exudation, hemorrhage, 
or fibrosis. Thus, if  we detect these lesions early, they are 
more amenable to treatment. Therefore, periodic screening is 
recommended for all patients with VHL (3).
There are various imaging modalities for the diagnosis of 
retinal angioma. Fluorescein angiography is the most pivotal 
because of the tumors rich vascularity. On the arterial phase 
of fluorescein angiography, there is a prominent dilated 
feeder arteriole along with an adjacent homogenously hyper-
fluorescent tumor because of a fine capillary network. The 
venous phase demonstrates an enlarged draining venule. 
Throughout the late phase of the angiogram, dye leaks into 
the surrounding tissues (1). While treatment planning, angi-
ography helps to differentiate arteriole from venule. Indocy-
anine green angiography (ICG) is an adjunct to differentiate 
Table 1: Studies on optical coherence tomography angiography findings of retinal capillary hemangioblastoma.
Reference Number 
of cases
Type of lesion Stage Main observations




Untreated RCH - 
stage B2a and stage 
B2c
No detailed description of the lesion.
Mainly post laser.
Suitable to monitor immediate post laser 
response.
Chou et al. (9) 1 eye Untreated solitary 
RCH
Stage B1b. 
3 feeder vessels 
present.
B scan OCT-A shows destruction of 
all layers of the retina with underlying 
shadowing. 
Appears like a hyperreflective mass but 
individual capillaries not seen.
Sagar et al. (10) 4 eyes 2 juxta-papillary 
hemangioblastoma
2 Untreated RCH
Case 2 – stage B1b 
RCH and 1 early stage 
B1a RCH lesion. 
Case 3 is same as that 
described in study 
number 4. 
Case 2- Early RCH OCT-A is not 
described in detail and not correlated with 
corresponding B-scan.
Emphasized of easier identification of 
feeder vessels and distinctness of lesions. 
Relation to various retinal layers not 
attempted.
Sagar et al. (11) 1 eye Untreated RCH Stage B1b.
Feeder vessels present.
Laser done.
Tumor vascular density shown for one 
lesion. No detailed description of lesion 
on OCT-A. No correlation made with 
corresponding B-scan image. 
Chun et al. (12) 2 eyes 2 early lesions –  
mentioned as 
subclinical angioma.
Stage B1a (case 1) 
and stage A0 (case 2) 
lesions but with no 
twin vessels.
Early lesions. No detailed description. No 
twin vessels seen.
RCH: retinal capillary hemangioblastoma; OCT-A: optical coherence tomography angiography.
Optical coherence tomography angiography of early stage 1a retinal hemangioblastoma in Von-Hippel-Lindau
 Journal of Kidney Cancer and VHL 2021; 8(3): 15–18  17
(A)
(C) (D) (E)Structural superficial AngioPlex superficial AngioPlex Deep
(B)
Figure 1: Fundus images shows lasered areas, multiple RCH, and localized retinal detachment. One of these lesions is a barely 
visible early stage 1a lesion (A- white arrow). B-scan OCT image (B) through this lesion showed the angioma is entirely intra-
retinal, well defined, and vertically oval. At the lower end, there is basal hypo-reflectivity with absence of an ellipsoid zone and 
an external limiting membrane. At the upper end, there is a focal hump but with maintained architecture of overlying inner 
retinal layers. En face structural appearance of the lesion on OCTA (C). An enface image of the superficial retinal layer (D), a 
focal increase in density and irregularity of the superficial capillary network with no prominent feeder vessels is seen. Adjacent 
capillary network is normal. An en face image of the deep retinal layers; a relatively more compact, well defined hyperreflective 
lesion is seen (E). VHL: Von-Hippel-Lindau; RCH: retinal capillary hemangioblastoma; OCTA: optical coherence tomography 
angiography.
choroidal lesions such as a chorioretinal neovascular mem-
brane or choroidal hemangioma from a retinal capillary 
hemangioma (4). Angioma originates as an inner retinal 
mass, manifesting as hyper-reflective thickening of the inner 
retinal layers on optical coherence tomography (OCT) and 
can displace outer retinal layers with increasing size. 
On histopathology, early-stage angiomas show foci of the 
nodular proliferation of the endothelial cells, abnormal cap-
illary vasculature with later development of reactive gliosis 
(5, 6). Recently, OCT angiography (OCTA) has become an 
established modality for noninvasive no-dye assessment of 
the three (superficial, middle, and deep) vascular layers of the 
retina (7). In literature, few reports have imaged RCH using 
OCTA (8–12). Most of these reports are on larger, late-stage 
angiomas with evident feeder vessels. Table 1 is a summary 
of these reports and the limitations in angioma descrip-
tion on OCTA. For the first time, this study gives a detailed 
description of OCTA (obtained using Zeiss Angioplex OCT 
machine) and its corresponding B-scan of an early stage 1a 
RCH tumor before the appearance of feeder vessels. 
A 33-year-old male diagnosed as VHL presented with 
decreased visual acuity in both eyes and no other systemic 
manifestations. Written informed consent was obtained from 
the patient for investigation, management, and publication 
purpose. He had a history of surgery in the past for spinal 
hemangioblastoma. Ocular examination detected multiple 
angiomas in zone 1 of the right eye and total retinal detach-
ment in the left eye. Left eye vitreoretinal surgery was under-
taken while the angiomas in the right eye were treated with 
direct retinal photocoagulation. The angiomas in the right 
eye remained stable, and some regressed following laser 
therapy. The patient underwent routine follow-up examina-
tion tri-monthly for early detection of any new angiomas. 
On a recent follow-up, no diminution of vision was noticed. 
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Fundus examination showed lasered areas, multiple RCH, 
and localized retinal detachment. One of these lesions was a 
barely visible early-stage 1a lesion (Figure 1A). 
A B-scan OCT lesion image revealed that the angioma was 
entirely intra-retinal, well defined, and vertically oval. The 
lower end had a basal hypo-reflectivity with the absence of 
an ellipsoid zone and an external limiting membrane. The 
upper end exhibited a focal hump with an intact overlying 
inner retinal layers (Figure 1B). 
On the en face image of superficial retinal layers (Figure 
1C-E), a focal increase in density and irregularity of the 
superficial capillary network with no prominent feeder ves-
sels and the normal adjacent capillary network was seen. En 
face imaging of deeper retinal layers showed a more compact 
and well defined lesion. This OCTA of early-stage lesion sug-
gests probable focal involvement of superficial and deep cap-
illary plexus of the retina. In addition to early detection, a 
further compilation of OCTA findings of early-stage lesions 
may also help us in understanding in-vivo changes and 
pathogenesis associated with RCH. 
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